Literature DB >> 18360115

Keratoacanthoma and infundibulocystic squamous cell carcinoma.

Steven Kossard1, Kong-Bing Tan, Carolyn Choy.   

Abstract

One of the major controversies in dermatopathology is the relationship of keratoacanthoma to squamous cell carcinoma. Leaders in the field remain polarized in their views. Carcinomas with distinct follicular pattern of differentiation have been described in reference to the isthmus as trichilemmal carcinomas, to the follicular bulb as pilomatricomal carcinomas, and to the stem cell or rapidly amplifying cell compartment as basal cell carcinomas (trichoblastic carcinomas). We have employed the term infundibulocystic or infundibular squamous cell carcinoma to identify a subset of squamous cell carcinomas that demonstrate this pattern of differentiation. The recognition of infundibular squamous cell carcinoma is important in that well-differentiated examples are likely to have been diagnosed as keratoacanthoma, whereas moderately or poorly differentiated tumors would be more often reported as squamous cell carcinomas, leading to underrecognition of these infundibular variants of squamous cell carcinoma. The descriptive term infundibulocystic or infundibular squamous cell carcinoma may help to better define an alternative follicular-based pathway to squamous cell carcinoma distinct from the more common evolution from solar keratoses and also refine the classification of keratoacanthoma.

Entities:  

Mesh:

Year:  2008        PMID: 18360115     DOI: 10.1097/DAD.0b013e318161310c

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  11 in total

Review 1.  [Actinic keratosis, Bowen's disease, keratoacanthoma and squamous cell carcinoma of the skin].

Authors:  M Majores; E Bierhoff
Journal:  Pathologe       Date:  2015-02       Impact factor: 1.011

2.  Infundibulocystic Squamous Cell Carcinoma.

Authors:  So Min Kim; Hyeree Kim; Hei Sung Kim; Sang Hyun Cho; Jeong Deuk Lee
Journal:  Ann Dermatol       Date:  2015-05-29       Impact factor: 1.444

3.  Analysis of dermatologic events in vemurafenib-treated patients with melanoma.

Authors:  Mario E Lacouture; Madeleine Duvic; Axel Hauschild; Victor G Prieto; Caroline Robert; Dirk Schadendorf; Caroline C Kim; Christopher J McCormack; Patricia L Myskowski; Olivia Spleiss; Kerstin Trunzer; Fei Su; Betty Nelson; Keith B Nolop; Joseph F Grippo; Richard J Lee; Matthew J Klimek; James L Troy; Andrew K Joe
Journal:  Oncologist       Date:  2013-03-01

Review 4.  Stem cell dynamics in the hair follicle niche.

Authors:  Panteleimon Rompolas; Valentina Greco
Journal:  Semin Cell Dev Biol       Date:  2013-12-17       Impact factor: 7.727

5.  Recurrent facial keratoacanthoma in a patient with diabetes: a case report.

Authors:  Esam Omar
Journal:  BMC Res Notes       Date:  2014-04-23

6.  Insulin-like growth factor 2 mRNA-binding protein-3 as a marker for distinguishing between cutaneous squamous cell carcinoma and keratoacanthoma.

Authors:  Akiko Kanzaki; Mitsuhiro Kudo; Shin-Ichi Ansai; Wei-Xia Peng; Kousuke Ishino; Tetsushi Yamamoto; Ryuichi Wada; Takenori Fujii; Kiyoshi Teduka; Kiyoko Kawahara; Yoko Kawamoto; Taeko Kitamura; Seiji Kawana; Hidehisa Saeki; Zenya Naito
Journal:  Int J Oncol       Date:  2016-01-05       Impact factor: 5.650

7.  Cutaneous squamous cell carcinoma manifesting as follicular isthmus cysts in a cat.

Authors:  Elizabeth A Layne; Melissa Graham
Journal:  JFMS Open Rep       Date:  2016-02-03

8.  Simulators of squamous cell carcinoma of the skin: diagnostic challenges on small biopsies and clinicopathological correlation.

Authors:  Kong-Bing Tan; Sze-Hwa Tan; Derrick Chen-Wee Aw; Huma Jaffar; Thiam-Chye Lim; Shu-Jin Lee; Yoke-Sun Lee
Journal:  J Skin Cancer       Date:  2013-06-25

9.  Keratoacanthoma Pathobiology in Mouse Models.

Authors:  Katherine N Gibson-Corley; Laura M Rogers; Adam Goeken; Adam J Dupuy; David K Meyerholz
Journal:  Diseases       Date:  2014-05-23

Review 10.  New described dermatological disorders.

Authors:  Müzeyyen Gönül; Bengu Cevirgen Cemil; Havva Ozge Keseroglu; Havva Kaya Akis
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.